Question 1

What specific markers will this study look for in my bile?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Bile Omics for Diagnosing Indeterminate Biliary Strictures clinical trial (NCT07007832). Contact the study team or your healthcare provider for specific answers.

Question 2

How might this new testing method change my diagnosis or treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Bile Omics for Diagnosing Indeterminate Biliary Strictures clinical trial (NCT07007832). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the risks or side effects of participating in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Bile Omics for Diagnosing Indeterminate Biliary Strictures clinical trial (NCT07007832). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my bile be collected during the ERCP procedure?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Bile Omics for Diagnosing Indeterminate Biliary Strictures clinical trial (NCT07007832). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I choose not to participate in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Bile Omics for Diagnosing Indeterminate Biliary Strictures clinical trial (NCT07007832). Contact the study team or your healthcare provider for specific answers.

Question 6

How will the results of this study be shared with me?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Bile Omics for Diagnosing Indeterminate Biliary Strictures clinical trial (NCT07007832). Contact the study team or your healthcare provider for specific answers.

What this study is about